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Abstract
Subacute sclerosing panencephalitis (SSPE) is related to “defective” measles virus or vaccination,
though an association with parainfluenza viruses has been reported. SSPE is characterized by a
slow, erratic course and elevated cerebrospinal fluid measles titers. An immunocompetent,
vaccinated infant, with onset of symptoms in parainfiuenza virus season and a catastrophic course
is described. Cerebrospinal fluid titers were negative, but postmortem brain had typical SSPE
lesions. Patient brain-derived RNA, subjected to reverse transcription followed by polymerase
chain reaction yielded polymerase chain reaction products with measles virus but not
parainfluenza virus genes. The sequenced fragment revealed multiple mutations, typical for SSPE.
SSPE can thus present in infants, with short latency and no cerebrospinal fluid antibodies. Viral
genomic analysis may be diagnostic, permitting early therapy.
The incidence of subacute sclerosing panencephalitis (SSPE), a fatal neurodegenerative
disease most commonly associated with prior measles infection [1, 2], has significantly
decreased in the United States [3]. Since the introduction of measles vaccines, age of onset
and vaccine-associated cases have increased [3]. Cases associated with parainfluenza virus
(PIV), relatively common in eastern Europe and the Middle East [4—6], have recently been
reported in this country [7]. New therapies, e.g., interferon, hold hope for affected
individuals, making timely diagnosis important [8, 9]. We report an infant who presented in
PIV season with no cerebrospinal fluid (CSF) measles antibodies and document the
diagnostic utility of molecular analysis of the virus.
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Materials and Methods
RNA Preparation. Reverse Transcription—Polymerase Chain Reaction and Sequencing
Frozen brain tissue specimens were ground in liquid nitrogen, and total cellular RNA was
extracted. RNA samples from measles virus (MV), or PIV type 1—, 2—, or 3—infected
Vero cells, were used as positive controls. Reverse transcription—polymerase chain reaction
(RT-PCR) was performed as described [10], using published primers specific for measles
matrix and fusion protein [11] genes. Three pairs of measles nucleocapsid protein gene-
specific nested primers, as follows, were developed: MN7/MN8 (5′-
CAATCTGGCCTTACCTTCGCAT-3′ / 5′-CTCCTTACCATCTCTTGCCCTA-3′); MV1/
MV2(5′-GCTAAGAAGGTGGATAAA-3′ / 5′-TATGCTGGATCAAAGTAAG-3′), and
MV3/MV4 (5′-TTGGAGAGAAAATGGTTGGA-3′ / 5′-
CAGAGCAGAGGGTATGAT-3′). Also developed was a primer pair, as follows,
recognizing conserved PIV-1, 2, and 3 nucleocapsid gene: PIN1/PIN2 (5′-
AATGCTGATGTCAAGTATGT-3′ / 5′-ATCCTGTCTGAATGCTTCTAA-3′)- A 410-bp
fragment of the matrix gene PCR product derived from two brain specimens was sequenced
along with a wild-type isolate.
Other Procedures
Magnetic resonance (MR) images (5 mm) were obtained on a 0.5-T magnet. CSF MV IgG
and IgM antibody titers were performed by MRL (Cypress, CA); aliquots were cultured for
viruses, including PIV. Brain specimens were stained with hematoxylin and eosin and Luxol
fast blue. Measles antigen immunofluorescence was performed, as well as herpesvirus and
cytomegalovirus immunohistochemical stains by using avidin-biotin methodology, and
electron microscopy.
Patient Report
A 22-month-old girl developed clumsiness and falling in December. Over the subsequent 2
weeks, focal and generalized myoclonic seizures developed, occurring hundreds of times
daily. There was no prior trauma, travel, drug ingestion, seizures, or abnormal movements,
and birth, infancy, and physical and neurological development had been normal. No excess
or unusual infections had occurred, and the child was apparently immunologically normal. A
febrile illness with rash had occurred at the age of 5 weeks, but there was no recent
infection. The measles—mumps—rubella vaccine had been administered at 18 months.
Initial physical and neurological examinations were normal, except for numerous 1 to 2-
second episodes of head drop, right arm jerk, or falling, without postictal fatigue. Blood
counts, chemistry, and liver function tests were normal. A brain magnetic resonance imaging
(MRI) scan showed focal areas of increased signal on T2-weighted images in the corona
radiata, left greater than right. Electroencephalogram (EEG) was abnormal with slow
background and multifocal epileptiform discharges, prominent in left central leads. The
patient was referred to Childrens Hospital Los Angeles, where somnolence, hypotonia,
hyperreflexia, and decreased right arm use were noted. Encephalopathy and loss of language
and social skills followed, probably compounded by large clonazepam doses. Video-EEG
showed almost continuous myoclonic seizures. A second MRI scan, 3 weeks later,
demonstrated progression of the corona radiata abnormalities (Fig 1a—c). CSF studies are
found in the Table.
Adrenocorticotropic hormone (150 U/m2/day) was given for 2 weeks. The child remained
stuporous, with frequent myoclonus. By the third month, persistent left gaze preference and
right hemiplegia were noted. An MRI scan was obtained (Fig 1d—f). The infant died of
aspiration pneumonia 3.5 months after illness onset.
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Results
The Table summarizes salient serology and CSF analyses. An MRI scan from the first
month shows focal increased signal in the corona radiata (see Fig 1a—c). Images obtained 6
weeks later show progression of bihemispheric white matter lesions (see Fig 1d—f) and
marked cerebral and cerebellar atrophy (see Fig 1d).
Autopsied brain weighed 915 gm (normal, 1,064 gm,). The cortical band was soft and pale,
and the white matter discolored and reduced. Deep gray nuclei, amygdaloid and
hippocampal formations, and tectum and tegmentum were softened and congested. The
leptomeninges contained a lymphocytic infiltrate. Diffuse neuronal loss and gliosis were
particularly severe in the cerebral and cerebellar cortex, hippocampi, and in diencephalic,
brainstem, and cerebellar nuclei. Demyelination, axonal degeneration, microglia
proliferation, hypertrophied astrocytes, and foamy macrophages were present throughout the
white matter (Fig 2a). Intranuclear eosinophilic inclusions (Cowdry A) were observed in
cortical neurons, oligodendrocytes, and astrocytes (Fig 2b). Measles, cytomegalovirus, and
herpesvirus immunocytochemistry was negative. Electron microscopic examination revealed
the intranuclear inclusions to contain helical, 14-nm diameter nucleocapsid tubules
characteristic of paramyxovirus (Fig 2c).
Patient brain-tissue samples (SSPE1, SSPE2) yielded PCR products of expected sizes with
measles specific primers MV1/MV2 (Fig 3A, lanes 2 and 4), MV3/ MV4 (lanes 9 and 11),
and MFP3/MFP4 (lanes 17 and 19). These comigrated with samples derived from a patient
with progressive MV encephalitis (lanes 5, 12, and 20) and with wild-type (lanes 8, 15, and
23) and vaccine MV (lanes 6, 13, 21). No PCR products were obtained with PIV-derived
consensus primers (Fig 3B). Patient-derived sequences of the 410-bp matrix gene fragment
differed from the wild-type by 12 bases. Eleven mutations were transitions [T(U)-C]; one
was a transversion. Three mutations resulted in amino acid substitutions; nine were “silent”
(Fig. 3C).
Discussion
SSPE is characterized by progressive dementia and myoclonic seizures [1—3], most
commonly subsequent to measles infection or vaccine. Age of onset in the United States,
averaging 14 years, has been increasing, with an average latency of 12 years from
antecedent measles infection and 7.73 years from vaccination [3]. SSPE incidence in the
United States has decreased dramatically with the advent of measles vaccine, averaging 4.2
cases per year [3]. One-sixth of SSPE patients lack a history of prior measles infection or
vaccination [3]. Recently, PIV-3 has been implicated in the etiology of SSPE-like
encephalitis in infants and children in this country ([7], Patient 2). Worldwide, PIV is a
significant cause of neurological diseases in children [12]. PIV antibody production in CSF
of SSPE patients and elevated serum titers to PIV-1 have been reported [4, 5]. PIV causes a
panencephalitis followed by white matter degeneration in infant mice [13] and is
indistinguishable microscopically from MV. In North America, epidemics of PIV affecting
infants and children occur infall and early winter, the time of onset of this infant’s illness.
The course of SSPE is typically stuttering and progressive [1—3], with 5% of patients
surviving 3 months or less, and 20% of patients surviving for 4 years or longer [2].
Inflammation and gliosis (“sclerosis”) are associated with Cowdry A viral inclusions, and an
etiological role has been established for a “defective” MV (reviewed in [1]). MV antigens
and RNA are found in CSF and brain of patients [1, 11]. In immunocompetent hosts
suspected of having SSPE, antibody production in the central nervous system is diagnostic
[1].
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Recent therapeutic successes for SSPE with interferon, and interferon—isoprinosine [9],
have been reported, providing impetus for early diagnosis, particularly in cases with atypical
history, course, and laboratory findings. This infant had illness onset in PIV season, 4
months after measles immunization. Atypical EEG and lack of CSF measles titers decreased
the likelihood of measles-associated SSPE. Autopsied brain verified the presence of SSPE
and of viral inclusions compatible with both MV and PIV [14]. RNA analysis confirmed the
etiological role of MV: PCR products were obtained only with MV primers. Further, the
sequenced fragment of measles matrix gene PCR product contained 12 mutations from
“wild-type” MV, of which five were T(U)-C transitions, typical for SSPE [15]. Sequence
information was insufficient to determine whether the patient’s SSPE strain was derived
from a vaccine [16] or wild-type [15, 17].
In conclusion, this 22-month-old infant, with a history of a “rash” at 5 weeks, had SSPE
without CSF measles antibodies. Robust central nervous system immunoglobiilin production
and neuropathological lesions exclude progressive measles encephalitis, seen in
immunocompromised individuals [1]. We speculate that measles infection in early infancy,
during the presence of maternal antibodies, led to tolerance to the virus, permitting its
survival and mutation. We suggest that PCR on CSF or biopsy specimens, and virus
identification in similar cases, may permit early therapeutic intervention and improved
outcome.
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Fig 1.
Axial magnetic resonance imaging (MR1) studies. T1 (TR 28 msec/TE 483 msec) (a, d),
intermediate (TR 48 msec/TE 2,500 msec) (b, e). and T2 (TR 96 msec/2,500 msec) (c, f)
weighted images through the corona radiata and bodies of the lateral ventricles, (a—c) Study
obtained 3 weeks after presentation. Focal areas of increased signal are present (arrows).
The lateral ventricles and cerebral sulci are normal in size, (d—f) MR1 done 2 months after
presentation. The focal areas of increased signal in the corona radiata have progressed and
involve large areas of the cortex (arrows). The lateral ventricles and cerebral sulci (curved
arrow) are enlarged, suggesting diffuse atrophy.
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Fig 2.
(a) Photomicrograph revealing white matter demyelination and gliosis. Perivascular
lymphocytic infiltrates are seen. (Hematoxylin and eosin-Luxol fast blue {H&E-LFB}
100×.) (b) Cranial nerve III nucleus neurons exhibiting Cowdry type A intranuclear
eosinophilic inclusions (arrowheads). (H&E-LFB, 200 ×.) (c) Intranuclear mass of viral
particles in an oligodendrocyte. Bar = 1 µm. Helical viral nudeocapsids are seen in greater
detail in the inset.
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Fig 3.
Polymerase chain reaction (PCR)-amplified fragments of viral genes from brain RNA
extracts. (A) Agarose gel electropboresis of PCR-amplified nucleocapsid protein (507 bp,
lanes 2—8; 368 bp, lanes 9—15), and fusion protein (367 bp, lanes 17—23) gene fragments
with measles virus (MV)-specific nested primers. Sample order for each primer set: current
patient (SSPE1), a child with “encephalitis,” current patient (duplicate, SSPE2), patient with
acquired immunodeficiency syndrome and progressive MV encephalitis, vaccine MV strain,
reaction mix without template, wild-type MV strain. (B) Nudeocapsid protein gene
fragments (323—330 bp) obtained with consensus parainfluenza virus (PIV) primers. RNA
from PIV-1, 2, and 3 (lanes 6—8); reaction mixture without RNA (lane 9);patient-derived
RNA (lanes 2—5) did not yield a signal. (C) Sequence of a 410-bp fragment of the matrix
gene of a wild-type MV (top rows), compared with the patient’s strain (bottom rows). Base
differences between the cDNA sequences of these strains and amino acid substitutions in the
derived polypeptides are indicated in bold type.
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Laboratory Investigation of Patients with Subacute Sclerosing Panencephalitis
Source Test Result Comments
CSF: I Cell count 4 white/0 red nl
Glucose/protein 56/23 (mg/dl) nl
Oligoclonal bands 2 nl = 0
IgG synthesis index 7.24 nl < 0.7
CSF: II Cell count 1 white/0 red nl
Glucose/protein 79/27 (mg/dl) nl
IgG synthesis index 6.05 nl < 0.7
CSF: III Cell count 1 white/0 red nl
Glucose/protein 79/22 (mg/dl) nl
Measles titers: IgM/IgG <1 : 1/1 :4 nl < 1 : 20/<1 :8
Serum Measles titers: IgM/IgG <1 : 20/>1 : 32 Immunity, remote
All three CSF specimen: viral cultures, negative; brain paramyxovirus culture, negative.
nl = normal
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